Zoetis Inc. (ETR:ZOE)

Market Cap	48.72B
Revenue (ttm)	8.01B
Net Income (ttm)	2.26B
Shares Out	n/a
EPS (ttm)	5.06
PE Ratio	21.56
Forward PE	19.44
Dividend	1.78 (1.61%)
Ex-Dividend Date	Oct 31, 2025

Volume	1,312
Average Volume	1,200
Open	111.06
Previous Close	110.72
Day's Range	110.38 - 111.82
52-Week Range	101.00 - 172.60
Beta	0.96
RSI	50.35
Earnings Date	Nov 4, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1950
• Employees: 13,800
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ZOE

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD